-
August 10: The Week in Cancer News
Organizations work to broaden eligibility for cancer clinical trials, and an article explores the limitations of personalized mouse models.
by Kate Yandell
-
August 3: The Week in Cancer News
A study indicates that being diagnosed with cancer as a child could lead to financial problems later, and the Trump administration relaxes restrictions on short-term health insurance policies.
by Kate Yandell
-
July 27: The Week in Cancer News
A study asks whether sunless tanning might encourage riskier tanning behavior, and an article investigates the supercomputer Watson's performance.
by Kate Yandell
-
July 20: The Week in Cancer News
A Chinese movie prompts political discourse about the cost of medication, and a study suggests that dining and sleeping habits may contribute to a person's risk of breast and prostate cancer.
by Brad Jones
-
July 13: The Week in Cancer News
An opinion piece discusses how the stigma surrounding opioids affects cancer patients, and a study provides data on treating melanoma patients with brain metastases.
by Kate Yandell
-
July 6: The Week in Cancer News
Studies explore what type of cervical cancer screening is most effective and whether patients with autoimmune diseases can take immunotherapy.
by Kate Yandell
-
June 29: The Week in Cancer News
Studies explore occupational hazards that could increase cancer risk, and the U.S. Food and Drug Administration approves a new combination therapy for melanoma.
by Kate Yandell
-
June 22: The Week in Cancer News
Experts debate direct-to-consumer genetic testing and studies shed light on breast reconstruction complications.
by Kate Yandell
Previous |
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles